It has been shown that heightened serum levels of caspase-3 correlate with poor outcome after stroke [12] and that minocycline, which is known to inhibit caspase-3 expression [14] in vivo, has a beneficial effect for patient outcome when administrated after stroke [13]. Here, CASP3 is linked to Stroke.